Your browser doesn't support javascript.
loading
Strategies to manage hepatitis C virus infection disease burden-Volume 4.
Chen, D S; Hamoudi, W; Mustapha, B; Layden, J; Nersesov, A; Reic, T; Garcia, V; Rios, C; Mateva, L; Njoya, O; Al-Busafi, S A; Abdelmageed, M K; Abdulla, M; Adda, D; Akin, O; Al Baqali, A; Al Dweik, N; Al Ejji, K; Al Ghazzawi, I; Al Kaabi, S; Al Naamani, K; Al Qamish, J; Al Sadadi, M; Al Salman, J; AlBadri, M; Al-Romaihi, H E; Ampofo, W; Antonov, K; Anyaike, C; Arome, F; Bane, A; Blach, S; Borodo, M M; Brandon, S M; Bright, B; Butt, M T; Cardenas, I; Chan, H L Y; Chen, C J; Chen, P J; Chien, R N; Chuang, W L; Cuellar, D; Derbala, M; Elbardiny, A A; Estes, C; Farag, E; Fung, J; Gamkrelidze, I; Genov, J.
Afiliação
  • Chen DS; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Hamoudi W; Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan.
  • Mustapha B; Jordan Ministry of Health, Amman, Jordan.
  • Layden J; IBN SINA Hospital, Rabat, Morocco.
  • Nersesov A; Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA.
  • Reic T; National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
  • Garcia V; European Liver Patients Association, Sint-Truiden, Belgium.
  • Rios C; Ministry of Public Health, Santo Domingo, Dominican Republic.
  • Mateva L; Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia.
  • Njoya O; University Hospital "St. Ivan Rilski", Sofia, Bulgaria.
  • Al-Busafi SA; Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon.
  • Abdelmageed MK; Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
  • Abdulla M; Hamad Medical Corporation, Doha, Qatar.
  • Adda D; Salmaniya Medical Complex, Manama, Bahrain.
  • Akin O; Civil Society Network on Hepatitis, Abuja, Nigeria.
  • Al Baqali A; Chagro-Care Trust (CCT), Jalingo, Nigeria.
  • Al Dweik N; Federal Ministry of Health, Abuja, Nigeria.
  • Al Ejji K; Al Kindi Specialised Hospital, Manama, Bahrain.
  • Al Ghazzawi I; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Al Kaabi S; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Al Naamani K; GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan.
  • Al Qamish J; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Al Sadadi M; Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman.
  • Al Salman J; Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahrain.
  • AlBadri M; Salmaniya Medical Complex, Manama, Bahrain.
  • Al-Romaihi HE; Salmaniya Medical Complex, Manama, Bahrain.
  • Ampofo W; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Antonov K; Ministry of Public Health Qatar, Doha, Qatar.
  • Anyaike C; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
  • Arome F; University Hospital "St. Ivan Rilski", Sofia, Bulgaria.
  • Bane A; Federal Ministry of Health, Abuja, Nigeria.
  • Blach S; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.
  • Borodo MM; Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia.
  • Brandon SM; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.
  • Bright B; Center for Disease Analysis (CDA), Lafayette, CO, USA.
  • Butt MT; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Cardenas I; Bayero University, Kano, Nigeria.
  • Chan HLY; Center for Disease Analysis (CDA), Lafayette, CO, USA.
  • Chen CJ; LiveWell Initiative (LWI), Lagos, Nigeria.
  • Chen PJ; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Chien RN; Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia.
  • Chuang WL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Cuellar D; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
  • Derbala M; Academia Sinica, Taipei, Taiwan.
  • Elbardiny AA; National Taiwan University, Taipei, Taiwan.
  • Estes C; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
  • Farag E; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
  • Fung J; Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia.
  • Gamkrelidze I; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Genov J; Ministry of Public Health Qatar, Doha, Qatar.
J Viral Hepat ; 24 Suppl 2: 44-63, 2017 10.
Article em En | MEDLINE | ID: mdl-29105286
ABSTRACT
The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-"WHO Targets" (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Saúde Global / Gerenciamento Clínico / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Saúde Global / Gerenciamento Clínico / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article